EHT 5372

Modify Date: 2025-08-20 07:58:11

EHT 5372 Structure
EHT 5372 structure
Common Name EHT 5372
CAS Number 1425945-60-3 Molecular Weight 383.40
Density N/A Boiling Point N/A
Molecular Formula C18H14FN5O2S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of EHT 5372


EHT 5372 is a strong inhibitor of DYRK’s family kinases, with IC50s of 0.22, 0.28 nM for DYRK1A and DYRK1B, respectively.

 Names

Name EHT 5372

 EHT 5372 Biological Activity

Description EHT 5372 is a strong inhibitor of DYRK’s family kinases, with IC50s of 0.22, 0.28 nM for DYRK1A and DYRK1B, respectively.
Related Catalog
Target

CLK1:22.8 nM (IC50)

Clk2:88.8 nM (IC50)

Clk4:59 nM (IC50)

GSK3α:7.44 nM (IC50)

GSK3β:221 nM (IC50)

DYRK1A:0.22 nM (IC50)

DYRK1B:0.28 nM (IC50)

DYRK2:10.8 nM (IC50)

DYRK3:93.2 nM (IC50)

In Vitro EHT 5372 is a strong inhibitor of DYRK’s family kinases, with IC50s of 0.22, 0.28 nM for DYRK1A and DYRK1B, respectively[1][2]. IC50 for DYRK2 and DYRK3 were higher (10.8 and 93.2 nM, respectively) and there was no inhibition on DYRK4. EHT 5372 displayed minimal impact on the CDC2-like kinase (CLK) family, with more than 100x selectivity over CLK1 (CLK1: IC50=22.8 nM; CLK2: IC50=88.8 nM; CLK3: IC50>10 lM; CLK4: no inhibition) and on the glycogen synthase kinase 3 (GSK3) family (GSK3α: IC50=7.44 nM; GSK3β: IC50=221 nM). EHT 5372 inhibits the direct phosphorylation of Tau by DYRK1A. EHT 5372 also normalizes both Aβ-induced Tau phosphorylation and DYRK1A-stimulated Aβ production[2].
Cell Assay HEK293 cells are changed with new culture medium and treated with 0.1-10 μM DYRK1A inhibitor EHT 5372 or 0.1% DMSO as vehicle for 24 h. The kinase inhibitor is tested in at least three independent experiments performed in duplicate. Cell viability is determined using a standard assay[2].
References

[1]. Chaikuad A, et al. An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases. J Med Chem. 2016 Nov 23;59(22):10315-10321.

[2]. Coutadeur S, et al. A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro. J Neurochem. 2015 May;133(3):440-51.

 Chemical & Physical Properties

Molecular Formula C18H14FN5O2S
Molecular Weight 383.40
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.